핵심기술
특허 / 논문
| Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective. |
|---|
| 등록일 :2018-03-28 18:04 조회수 :20,560 |
|
Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective. Han C, Kwon BS.
Abstract Chimeric antigen receptor (CAR) T cells have outstanding therapeutic potential for treating blood cancers. The prospects for this technology have accelerated basic research, clinical translation and Big Pharma's investment in the field of T-cell therapeutics. This interest has led to the discovery of key factors that affect CAR T-cell efficacy and play pivotal roles in T-cell immunology. Herein, we introduce advances in adoptive immunotherapy and the birth of CAR T cells, and review CAR T-cell studies that focus on three important features: CAR constructs, target antigens and T-cell phenotypes. At last, we highlight novel strategies that overcome the tumor microenvironment and circumvent CAR T-cell side effects, and consider the future direction of CAR T-cell development. KEYWORDS: adoptive immunotherapy; cancer; chimeric antigen receptor T-cell
Immunotherapy. 2018 Mar;10(3):221-234. doi: 10.2217/imt-2017-0133.
논문 링크(클릭 시 이동) |